Immune Globulin Subcutaenous (Human), 20%

Clinical trial NCT01412385 · COMPLETED

Trial details

NCT number: NCT01412385
Sponsor: Baxalta now part of Shire
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Primary Immunodeficiency Diseases (PID)

Start date: 2011-06-20
Primary completion: 2014-05-13
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.